<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
  <channel>
    <title>Leadership Updates - Quantisnow</title>
    <description>Executive and board changes, as they happen.</description>
    <link>https://www.quantisnow.com/news/leadership-updates</link>
    <language>en-us</language>
    <lastBuildDate>Thu, 13 Aug 2026 07:13:09 GMT</lastBuildDate>
    <item>
      <title>Duolingo Invests in World-Class Motion Design with Acquisition of Animade</title>
      <description>PITTSBURGH, Aug.  13, 2026  (GLOBE NEWSWIRE) -- Duolingo, Inc. (NASDAQ:DUOL), the world&apos;s leading mobile learning platform, announced today it has acquired Animade, a London-based animation and motion design studio recognized for its work in product storytelling, brand, interactive experiences, and character animation. The acquisition expands Duolingo&apos;s Design Studio, strengthening a capability that has become increasingly important to delivering engaging product experiences and accelerating innovation.  &quot;Great products aren&apos;t defined only by what they do, but by how they make people feel,&quot; said Mig Reyes, Head of Design at Duolingo. &quot;Motion design has become a core part of how we help learn</description>
      <link>https://www.quantisnow.com/insight/duolingo-invests-in-world-class-motion-design-with-acquisition-of-animade-6678921</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/duolingo-invests-in-world-class-motion-design-with-acquisition-of-animade-6678921</guid>
      <pubDate>Thu, 13 Aug 2026 04:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Accuray Advances Strategic Priorities Through Key Executive Leadership Appointments</title>
      <description>MADISON, Wis., Aug. 12, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) announced two key leadership appointments intended to improve operational execution and profitability, deliver increased customer value, and enhance overall enterprise performance as the company continues to advance the strategic priorities in its recently announced transformation plan focused on sustainable, profitable growth.
    
                
                    
                
    
As part of these efforts, Accuray has named Todd Brown to lead the company&apos;s newly created Enterprise Performance Optimization organization and has appointed Sofiane Laoussadi as Senior Vice President, Global Services &amp; Solut</description>
      <link>https://www.quantisnow.com/insight/accuray-advances-strategic-priorities-through-key-executive-leadership-appointments-6678550</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/accuray-advances-strategic-priorities-through-key-executive-leadership-appointments-6678550</guid>
      <pubDate>Wed, 12 Aug 2026 21:09:00 GMT</pubDate>
    </item>
    <item>
      <title>Cinemark Announces Quarterly Cash Dividend and Addition to Board of Directors</title>
      <description>
Declares quarterly cash dividend of $0.09


Appoints Lawrence Burian to Board of Directors


Cinemark Holdings, Inc. (&quot;Cinemark&quot;) (NYSE:CNK), one of the largest and most influential theatrical exhibition companies in the world, announced today that its Board of Directors has declared a quarterly cash dividend of $0.09 per share of common stock. The dividend will be paid on September 9, 2026, to stockholders of record on August 26, 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260812693893/en/Lawrence Burian joins Cinemark Board of Directors
Also announced today, Lawrence Burian has been elected as a Class II director of C</description>
      <link>https://www.quantisnow.com/insight/cinemark-announces-quarterly-cash-dividend-and-addition-to-board-of-6678172</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/cinemark-announces-quarterly-cash-dividend-and-addition-to-board-of-6678172</guid>
      <pubDate>Wed, 12 Aug 2026 20:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results</title>
      <description>
Interim Analysis Supports Expansion of GX-03 Phase 2 Study to a Broader Population of Atopic Dermatitis Patients, Including Patients with Moderate-to-Severe Lesions but Lower Overall Disease Extent


Dr. Stephen M. Hahn, Former FDA Commissioner, Appointed Executive Clinical and Regulatory Lead


First Peer-Reviewed Publication Shows GX-03 Significantly Reduced Skin Inflammation in Preclinical Study


Company Plans to Expand GX-03 Pipeline into Hidradenitis Suppurativa, with First Patient Dosing Targeted for Q2 2027


Phase 2 Enrollment Expected to Complete in Fourth Quarter of 2026; Company Expects Cash to Fund Operations into Third Quarter of 2027


Turn Therapeutics Inc. (NASDAQ:TTRX), a </description>
      <link>https://www.quantisnow.com/insight/turn-therapeutics-provides-corporate-updates-and-reports-second-quarter-2026-6678168</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/turn-therapeutics-provides-corporate-updates-and-reports-second-quarter-2026-6678168</guid>
      <pubDate>Wed, 12 Aug 2026 20:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Centuri Announces Executive Leadership Changes</title>
      <description>
Centuri Holdings, Inc. (NYSE:CTRI) (&quot;Centuri&quot; or the &quot;Company&quot;), a leading North American utility and energy infrastructure services company, today announced the appointments of Kelly Youngblood as Executive Vice President, Chief Financial Officer, succeeding Gregory A. Izenstark, and Danielle Hunter as Executive Vice President, Chief Legal &amp; Administrative Officer and Corporate Secretary, succeeding Jason S. Wilcock. Both appointments are effective immediately.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260812637291/en/Danielle Hunter joins Centuri as Executive Vice President, Chief Legal &amp; Administrative Officer and Corpor</description>
      <link>https://www.quantisnow.com/insight/centuri-announces-executive-leadership-changes-6677983</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/centuri-announces-executive-leadership-changes-6677983</guid>
      <pubDate>Wed, 12 Aug 2026 20:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Resideo Appoints Shane Harrison as Chief Financial Officer</title>
      <description>SCOTTSDALE, Ariz., Aug. 12, 2026 /PRNewswire/ -- Resideo Technologies (NYSE:REZI) (&quot;Resideo&quot;), a leading global developer and manufacturer of critical control and sensing solutions for residential end markets, today announced that Shane Harrison has been appointed as Resideo&apos;s Chief Financial Officer, effective September 1, 2026.
    
                
                    
                
    
Mr. Harrison is a seasoned finance leader with more than 25 years of experience across corporate finance, investor relations, and strategic transactions. He joins Resideo from NRC Health, a publicly traded healthcare technology and analytics company, where he served as Chief Financial Officer and was p</description>
      <link>https://www.quantisnow.com/insight/resideo-appoints-shane-harrison-as-chief-financial-officer-6677832</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/resideo-appoints-shane-harrison-as-chief-financial-officer-6677832</guid>
      <pubDate>Wed, 12 Aug 2026 20:06:00 GMT</pubDate>
    </item>
    <item>
      <title>Byrna Appoints Retired U.S. Army Brigadier General Rose Lopez Keravuori to Board of Directors</title>
      <description>ANDOVER, Mass., Aug.  12, 2026  (GLOBE NEWSWIRE) -- Byrna Technologies Inc. (&quot;Byrna&quot; or the &quot;Company&quot;) (NASDAQ:BYRN), a personal defense technology company specializing in the development, manufacture, and sale of innovative less-lethal personal security solutions, today announced the appointment of retired U.S. Army Brigadier General Rose Lopez Keravuori to its Board of Directors (the &quot;Board&quot;), effective August 10, 2026. She has also been named, along with two other independent directors, Board Chair TJ Kennedy and Adam Roth, and CEO Conn Davis, to a newly formed Enterprise Risk Management Committee to assist the Board in its strategic oversight of risk management. Keravuori succeeds Emily </description>
      <link>https://www.quantisnow.com/insight/byrna-appoints-retired-us-army-brigadier-general-rose-lopez-keravuori-6677750</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/byrna-appoints-retired-us-army-brigadier-general-rose-lopez-keravuori-6677750</guid>
      <pubDate>Wed, 12 Aug 2026 20:05:00 GMT</pubDate>
    </item>
    <item>
      <title>OptimizeRx Announces Finance Leadership Appointments to  Support the Next Phase of Growth</title>
      <description>The Company Names Andy D’Silva as the next Chief Financial Officer and Heather Favazza as Chief Accounting Officer effective January 1, 2027    Planned Transition Reflects Strong Succession Planning and Deep Leadership Bench    WALTHAM, Mass., Aug.  12, 2026  (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the &quot;Company&quot;) (NASDAQ:OPRX), a leading healthcare technology company enabling life sciences organizations to deliver smarter, more personalized engagement across the healthcare ecosystem, today announced a finance leadership transition that reflects the Company’s disciplined succession planning, deep leadership bench, and confidence in its long-term strategy.    The Company’s Board of Directors has</description>
      <link>https://www.quantisnow.com/insight/optimizerx-announces-finance-leadership-appointments-to-support-the-next-phase-6677746</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/optimizerx-announces-finance-leadership-appointments-to-support-the-next-phase-6677746</guid>
      <pubDate>Wed, 12 Aug 2026 20:05:00 GMT</pubDate>
    </item>
    <item>
      <title>UBS Welcomes Two-Person Advisor Team in Kenwood, Ohio</title>
      <description>
UBS today announced that Financial Advisors Mitch Edwards and Jeff Stanley have joined the firm’s Kenwood office from Morgan Stanley. Their team, The Stanley Edwards Group, will be part of the UBS Ohio–Indiana–Kentucky Market, led by Market Executive Andrew Dempsey.


&quot;We are pleased to welcome Mitch and Jeff to UBS,&quot; said Andrew. &quot;They bring substantial industry experience, a strong commitment to their clients and deep relationships in the Ohio market. Their decision to join UBS reflects our continued ability to attract experienced advisors who value the firm’s global resources, wealth management capabilities and client-first culture.&quot;


Mitch Edwards joins UBS with extensive experience se</description>
      <link>https://www.quantisnow.com/insight/ubs-welcomes-two-person-advisor-team-in-kenwood-ohio-6677395</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/ubs-welcomes-two-person-advisor-team-in-kenwood-ohio-6677395</guid>
      <pubDate>Wed, 12 Aug 2026 15:09:00 GMT</pubDate>
    </item>
    <item>
      <title>Tri Pointe Homes Makes a Return to Poulsbo With Latest Community, Plateau at Liberty Bay</title>
      <description>
63-home neighborhood marks builder’s 8th community in Poulsbo since 2007


Tri Pointe Homes®, one of the nation’s largest homebuilders, is excited to celebrate the grand opening of its newest community, Plateau at Liberty Bay, on Saturday, Aug. 15. This new single-family home community builds upon the company’s nearly 20-year legacy of creating thoughtfully designed neighborhoods in Poulsbo, marking Plateau at Liberty Bay as the builder’s eighth neighborhood in the city.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260812699157/en/Plateau at Liberty Bay homes feature a relaxed coastal craftsmanship design style. Photo credit: </description>
      <link>https://www.quantisnow.com/insight/tri-pointe-homes-makes-a-return-to-poulsbo-with-latest-6677391</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/tri-pointe-homes-makes-a-return-to-poulsbo-with-latest-6677391</guid>
      <pubDate>Wed, 12 Aug 2026 15:04:00 GMT</pubDate>
    </item>
    <item>
      <title>Eagle Bancorp, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</title>
      <description>BETHESDA, Md., Aug.  12, 2026  (GLOBE NEWSWIRE) -- Eagle Bancorp, Inc. (the &quot;Company&quot;), the holding company for EagleBank, today announced that, in connection with the appointment of Stephen R. Curley as President and Chief Executive Officer of the Company and EagleBank, the Company granted employment inducement equity awards to Mr. Curley on August 10, 2026, as a material inducement to his entering into employment with the Company and EagleBank and pursuant to the terms of his employment agreement, which was previously filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 12, 2026.  The inducement awards consisted of (i) sign-on inducement awards comprising 26,049 p</description>
      <link>https://www.quantisnow.com/insight/eagle-bancorp-inc-announces-inducement-grants-under-nasdaq-listing-rule-6677332</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/eagle-bancorp-inc-announces-inducement-grants-under-nasdaq-listing-rule-6677332</guid>
      <pubDate>Wed, 12 Aug 2026 13:58:47 GMT</pubDate>
    </item>
    <item>
      <title>Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates</title>
      <description>WILMETTE, Ill., Aug.  12, 2026  (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (&quot;Monopar&quot; or the &quot;Company&quot;) (NASDAQ:MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced second quarter 2026 financial results and provided business updates.  Recent Program Developments  ALXN1840 for Wilson Disease – Rolling NDA Submission Initiated  On July 22, 2026, Monopar announced it had initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for ALXN1840. The FDA authorized Monopar to submit the NDA on a rolling basis, allowing completed sections of the application to </description>
      <link>https://www.quantisnow.com/insight/monopar-therapeutics-reports-second-quarter-2026-financial-results-and-provides-6677312</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/monopar-therapeutics-reports-second-quarter-2026-financial-results-and-provides-6677312</guid>
      <pubDate>Wed, 12 Aug 2026 13:30:00 GMT</pubDate>
    </item>
    <item>
      <title>ASTROTECH APPOINTS STRATEGIC ADVISORY BOARD TO HELP ADVANCE LUNAR RESOURCES AND INFRASTRUCTURE INITIATIVE</title>
      <description>AUSTIN, Texas, Aug.  12, 2026  (GLOBE NEWSWIRE) --  Astrotech Corporation (NASDAQ:ASTC) (&quot;Astrotech&quot; or the &quot;Company&quot;), today announced the formation of its Strategic Advisory Board and the appointment of four inaugural members: Dennis Wingo; Maj. Gen. (Ret.) John M. Olson, Ph.D.; Clive R. Neal, Ph.D.; and Gregory R. &quot;Greg&quot; Baiden, Ph.D. The advisors will also support the Company&apos;s planned response to NASA&apos;s Next Space Technologies for Exploration Partnerships-3 (&quot;NextSTEP-3&quot;) Appendix A: Lunar Enabling Infrastructure Accelerator (&quot;LEIA&quot;) (&quot;Appendix A Proposal&quot;).  The Strategic Advisory Board is expected to provide technical and strategic guidance as the Company evaluates technology prioriti</description>
      <link>https://www.quantisnow.com/insight/astrotech-appoints-strategic-advisory-board-to-help-advance-lunar-resources-6677282</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/astrotech-appoints-strategic-advisory-board-to-help-advance-lunar-resources-6677282</guid>
      <pubDate>Wed, 12 Aug 2026 13:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Rimini Street Expands C-Suite Leadership for Growth with Appointment of Two Proven Industry Veterans as Chief Operating Officer and Chief Delivery Officer</title>
      <description>
Rimini Street appoints Keith Costello as EVP and Chief Operating Officer and Alexander Guasch as EVP and Chief Delivery Officer


Rimini Street, Inc. (NASDAQ:RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced the appointment of Keith Costello as chief operating officer (COO) and Alexander Guasch as chief delivery officer (CDO).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260812127732/en/Rimini Street Expands C-Suite Leadership for Growth with Appointment of Two Proven Industry Veterans as Chief Operating Officer and Chief De</description>
      <link>https://www.quantisnow.com/insight/rimini-street-expands-c-suite-leadership-for-growth-with-appointment-of-6677245</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/rimini-street-expands-c-suite-leadership-for-growth-with-appointment-of-6677245</guid>
      <pubDate>Wed, 12 Aug 2026 13:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Alight Expands Expertise Across Leaves and Consultant Partnerships With Appointment of Three Seasoned Executives</title>
      <description>
New hires bring deep expertise across clinical operations, delivery transformation and consultant and broker relationships reflective of Alight’s continued commitment to service and operational excellence 


Alight, Inc. (NYSE:ALIT), a leading benefits administration provider of health, wealth and leave solutions, today announced the appointments of three seasoned executives across Consultant and Broker Partnerships, Leaves Clinical Operations and Leaves Delivery Transformation, continuing the company’s investment in deep expertise and capabilities across the organization.


Jodi Bryant has been named Senior Vice President, Consultant &amp; Broker Relationships; Dr. Steven Serra has been named </description>
      <link>https://www.quantisnow.com/insight/alight-expands-expertise-across-leaves-and-consultant-partnerships-with-appointment-6677241</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/alight-expands-expertise-across-leaves-and-consultant-partnerships-with-appointment-6677241</guid>
      <pubDate>Wed, 12 Aug 2026 13:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Energy Fuels&apos; Acquisition of Australian Strategic Materials Wins Shareholder Approval</title>
      <description>ASM shareholder approval marks a key step toward completing Energy Fuels&apos; acquisition of ASM and advancing its rare earth mining, metals and alloys capabilityDENVER, Aug. 12, 2026 /CNW/ - Energy Fuels Inc. (NYSE:UUUU) (TSX:EFR) (&quot;Energy Fuels&quot; or the &quot;Company&quot;), a leading U.S. producer of uranium, rare earth elements (&quot;REE&quot;), and other critical minerals, is pleased to announce it has reached a major milestone toward its planned acquisition of Australian Strategic Materials Limited (ASX: ASM) (&quot;ASM&quot;), with ASM Securityholders overwhelmingly voting in favor of the transaction at the Scheme Meetings held in Perth, Australia on August 12, 2026.
    
                
                    
        </description>
      <link>https://www.quantisnow.com/insight/energy-fuels-acquisition-of-australian-strategic-materials-wins-shareholder-approval-6677196</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/energy-fuels-acquisition-of-australian-strategic-materials-wins-shareholder-approval-6677196</guid>
      <pubDate>Wed, 12 Aug 2026 12:35:00 GMT</pubDate>
    </item>
    <item>
      <title>VEON&apos;s Banglalink Receives Bangladesh Bank Approval to Launch Digital Payment Service Mukto Pay</title>
      <description>Banglalink targets September 2026 commercial launch as new licence advances VEON&apos;s digital financial services ambitions  Dubai, Dhaka, and New York, August 12, 2026: VEON Ltd. (NASDAQ:VEON) today announced that its Bangladesh operating company Banglalink has received a Payment Service Provider (PSP) licence from Bangladesh Bank, the central bank of Bangladesh, paving the way for its entry into the country&apos;s digital payments market. Banglalink will launch its digital payment services under the brand Mukto Pay, a fully owned Banglalink service designed to provide customers with simple, secure and accessible digital payment solutions. The name &quot;Mukto,&quot; meaning &quot;freedom&quot; in Bengali, reflects Ban</description>
      <link>https://www.quantisnow.com/insight/veons-banglalink-receives-bangladesh-bank-approval-to-launch-digital-payment-6677174</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/veons-banglalink-receives-bangladesh-bank-approval-to-launch-digital-payment-6677174</guid>
      <pubDate>Wed, 12 Aug 2026 12:30:28 GMT</pubDate>
    </item>
    <item>
      <title>Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri</title>
      <description>CRANFORD, N.J., Aug. 12, 2026 /PRNewswire/ -- Citius Oncology, Inc. (&quot;Citius Oncology&quot;) (NASDAQ:CTOR), an oncology-focused biopharmaceutical company and majority-owned subsidiary of Citius Pharmaceuticals, Inc. (&quot;Citius Pharma&quot;) (NASDAQ:CTXR), today announced that its Board of Directors voted to appoint Jonathan Peri, Ph.D., J.D., as an additional independent director, effective August 10, 2026. Following a unanimous vote of approval by the Board, the appointment expands the Company&apos;s Board of Directors to nine members.
    
                
                    
                
    
Dr. Peri brings three decades of leadership across higher education, financial services, law, and corporate g</description>
      <link>https://www.quantisnow.com/insight/citius-oncology-expands-board-with-appointment-of-independent-director-jonathan-6677091</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/citius-oncology-expands-board-with-appointment-of-independent-director-jonathan-6677091</guid>
      <pubDate>Wed, 12 Aug 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Keurig Dr Pepper Announces Appointment of New Director to its Board</title>
      <description>FRISCO, Texas and BURLINGTON, Mass., Aug. 12, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ:KDP) announced today that Aaron Alt has been appointed a director of the Company&apos;s Board of Directors, effective August 14, 2026.Alt brings deep expertise in finance, capital allocation and business transformation to KDP&apos;s Board and will serve on its Audit and Finance Committee. He currently serves as Chief Financial Officer of Cardinal Health, where he oversees the company&apos;s financial and corporate development activities. Prior to joining Cardinal Health in 2023, Alt served as Executive Vice President and Chief Financial Officer of Sysco Corporation and held senior finance and operational leader</description>
      <link>https://www.quantisnow.com/insight/keurig-dr-pepper-announces-appointment-of-new-director-to-its-6677079</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/keurig-dr-pepper-announces-appointment-of-new-director-to-its-6677079</guid>
      <pubDate>Wed, 12 Aug 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Everspin Technologies Appoints Vikas Choudhary to Board of Directors</title>
      <description>
Semiconductor executive brings more than 30 years of experience and a buyer-side perspective on data center and AI infrastructure


Everspin Technologies, Inc. (NASDAQ:MRAM), the world’s leading developer and manufacturer of Magnetoresistive Random Access Memory (MRAM) persistent memory solutions, today announced the appointment of Vikas Choudhary to its board of directors, effective August 10, 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260812611306/en/Everspin&apos;s newest board member, Vikas Choudhary.
Choudhary has held various executive management positions spanning engineering, product strategy, sales and general mana</description>
      <link>https://www.quantisnow.com/insight/everspin-technologies-appoints-vikas-choudhary-to-board-of-directors-6677073</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/everspin-technologies-appoints-vikas-choudhary-to-board-of-directors-6677073</guid>
      <pubDate>Wed, 12 Aug 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors</title>
      <description>CONSHOHOCKEN, Pa., Aug.  12, 2026  (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced it has appointed John C. Reed, M.D., Ph.D., to its Board of Directors.  Dr. Reed currently serves as Executive Vice President, Innovative Medicine, Research &amp; Development at Johnson &amp; Johnson (&quot;J&amp;J&quot;) and is a member of J&amp;J’s Executive Committee, where he leads research and development across oncology, immunology, neuroscience and other areas of significant unmet medical need.  Julian Baker, Chairman of the Board of Directors of Madrigal, stated, &quot;I </description>
      <link>https://www.quantisnow.com/insight/madrigal-appoints-john-c-reed-md-phd-to-its-board-6677059</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/madrigal-appoints-john-c-reed-md-phd-to-its-board-6677059</guid>
      <pubDate>Wed, 12 Aug 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>High Roller Technologies Appoints Thomas Scaria as Chief Product Officer</title>
      <description>Product and financial markets executive to lead ROLR prediction markets platform development, launch execution and global product strategy  LAS VEGAS, Nevada, Aug.  12, 2026  (GLOBE NEWSWIRE) -- High Roller Technologies, Inc. (&quot;High Roller&quot; or the &quot;Company&quot;) (NYSE:ROLR), a publicly traded online gaming and prediction markets company, today announced the appointment of Thomas Scaria, CFA, to the newly created position of Chief Product Officer, reporting to CEO Seth Young. The creation of the Chief Product Officer position further expands High Roller’s leadership and product-development capabilities as the Company prepares to launch ROLR prediction markets and continues to invest in its broade</description>
      <link>https://www.quantisnow.com/insight/high-roller-technologies-appoints-thomas-scaria-as-chief-product-officer-6677045</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/high-roller-technologies-appoints-thomas-scaria-as-chief-product-officer-6677045</guid>
      <pubDate>Wed, 12 Aug 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Electra Appoints Peter Rawlins as Chief Financial Officer; Reports Second Quarter 2026 Results</title>
      <description>TORONTO, Aug.  12, 2026  (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ:ELBM, TSXV:ELBM) (&quot;Electra&quot; or the &quot;Company&quot;) today announced the appointment of Peter Rawlins as Chief Financial Officer (CFO), effective August 26, 2026.  Peter brings over two decades of mining finance, capital markets and strategic advisory experience. He spent 19 years at CIBC, most recently as Managing Director, Global Mining &amp; Forest Products in Capital Markets, where he advised mining clients on a broad range of financing, transaction and growth initiatives, including project and acquisition financings, corporate finance solutions and streaming transactions.  Peter is a seasoned banking executi</description>
      <link>https://www.quantisnow.com/insight/electra-appoints-peter-rawlins-as-chief-financial-officer-reports-second-6676977</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/electra-appoints-peter-rawlins-as-chief-financial-officer-reports-second-6676977</guid>
      <pubDate>Wed, 12 Aug 2026 11:15:00 GMT</pubDate>
    </item>
    <item>
      <title>High Tide Announces Voting Results of Annual General and Special Meeting of Shareholders</title>
      <description>CALGARY, AB, Aug. 12, 2026 /CNW/ -- High Tide Inc. (&quot;High Tide&quot; or the &quot;Company&quot;) (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today the voting results from its annual general and special meeting of shareholders of the Company held on August 11, 2026 (the &quot;Meeting&quot;). Each nominee listed in the Company&apos;s management information circular dated June 29, 2026, was elected as a director of the Company.
    
                
                    
                
    
Each of the following five nominees proposed by management was elected as a director of the Company. The results of su</description>
      <link>https://www.quantisnow.com/insight/high-tide-announces-voting-results-of-annual-general-and-special-6676787</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/high-tide-announces-voting-results-of-annual-general-and-special-6676787</guid>
      <pubDate>Wed, 12 Aug 2026 10:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market</title>
      <description>Files six new lawsuits as company escalates fight to protect patientsINDIANAPOLIS, Aug. 12, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today escalated its continued fight to protect patients from the dangerous black market for retatrutide, filing six new lawsuits against U.S. entities selling black-market products in addition to having referred hundreds of bad actors to regulators and law enforcement worldwide. Lilly is also calling on the entities that sellers use to conduct their illegal business—social media and e-commerce platforms, credit card companies, payment processors and shipping and logistics carriers—to help protect patients and fight this illicit activity. According </description>
      <link>https://www.quantisnow.com/insight/lilly-calls-on-online-platforms-payment-companies-and-regulators-to-6676771</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/lilly-calls-on-online-platforms-payment-companies-and-regulators-to-6676771</guid>
      <pubDate>Wed, 12 Aug 2026 09:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Generation Partners announces sale of Captivate Network to National CineMedia (NASDAQ: NCMI)</title>
      <description>GREENWICH, Conn. and AUSTIN, Texas and LOS ANGELES, Aug. 11, 2026 /PRNewswire/ -- Generation Partners (www.generation.com) today announced the sale of its majority ownership position in Captivate Holdings LLC (&quot;Captivate&quot; or the &quot;Company&quot;), the leading operator of digital video elevator and lobby advertising in North America, to National CineMedia, Inc. (&quot;NCM&quot;) (NASDAQ:NCMI), the largest cinema advertising platform in the U.S.
    
                
                    
                
    
Founded in 1997, Captivate operates a digital out-of-home media network comprised of more than 26,000 screens located in commercial office buildings and residential properties across 170 U.S. and Canadian</description>
      <link>https://www.quantisnow.com/insight/generation-partners-announces-sale-of-captivate-network-to-national-cinemedia-6676620</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/generation-partners-announces-sale-of-captivate-network-to-national-cinemedia-6676620</guid>
      <pubDate>Tue, 11 Aug 2026 22:23:00 GMT</pubDate>
    </item>
    <item>
      <title>NOVAGOLD &amp; Paulson Announce the Appointment of Endeavour Financial and Macquarie Capital  as Financial Advisors to the Donlin Gold Project</title>
      <description>VANCOUVER, British Columbia, Aug.  11, 2026  (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (&quot;NOVAGOLD&quot; or the &quot;Company&quot;) ((NYSE American, TSX:NG) and Donlin Gold Holdings LLC (DGH), 100% wholly-owned by Paulson Advisers LLC and its affiliates (&quot;Paulson&quot;), are pleased to announce the appointment of Endeavour Financial (&quot;Endeavour&quot;), and Macquarie Capital (&quot;Macquarie&quot;) (collectively, the &quot;Financial Advisors&quot;) to provide financial advisory services for the development of the Donlin Gold project in Alaska and to support the arrangement of project and infrastructure financing.  Strategy and Mandate  As part of the mandate, the Financial Advisors will assist Donlin Gold in evaluating funding alterna</description>
      <link>https://www.quantisnow.com/insight/novagold-paulson-announce-the-appointment-of-endeavour-financial-and-macquarie-6676275</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/novagold-paulson-announce-the-appointment-of-endeavour-financial-and-macquarie-6676275</guid>
      <pubDate>Tue, 11 Aug 2026 20:45:00 GMT</pubDate>
    </item>
    <item>
      <title>MATTHEWS INTERNATIONAL CORPORATION ANNOUNCES THE APPOINTMENT OF MICHAEL J. WHITEHEAD AS PRESIDENT AND CHIEF EXECUTIVE OFFICER</title>
      <description>PITTSBURGH, Aug. 11, 2026 /PRNewswire/ -- Matthews International Corporation (NASDAQ GSM: MATW) (&quot;Matthews&quot; and/or the &quot;Company&quot;) today announced that its Board of Directors has appointed Michael J. Whitehead as President and Chief Executive Officer, succeeding Joseph C. Bartolacci, who recently announced his intention to retire following more than two decades of leadership of the Company.
    
                
                    
                
    
The appointment follows a comprehensive and deliberate succession planning process led by the Board of Directors to identify the executive best positioned to lead Matthews into its next phase of evolution, innovation, and value creation.Follo</description>
      <link>https://www.quantisnow.com/insight/matthews-international-corporation-announces-the-appointment-of-michael-j-whitehead-6676115</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/matthews-international-corporation-announces-the-appointment-of-michael-j-whitehead-6676115</guid>
      <pubDate>Tue, 11 Aug 2026 20:30:00 GMT</pubDate>
    </item>
    <item>
      <title>The Hartford Appoints Priscilla Almodovar To Its Board of Directors</title>
      <description>
The Hartford announced that Priscilla Almodovar, former president and CEO of Fannie Mae, has been elected to the company’s Board of Directors, effective Sept. 1. She will serve on the board’s Finance, Investment and Risk Management Committee, as well as the Audit Committee.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260811180836/en/Priscilla Almodovar
&quot;Priscilla is an accomplished executive with deep expertise in financial services, capital management, enterprise risk management and governance,&quot; said The Hartford’s Chairman and CEO Christopher Swift. &quot;Her experience leading large, complex organizations and overseeing signifi</description>
      <link>https://www.quantisnow.com/insight/the-hartford-appoints-priscilla-almodovar-to-its-board-of-directors-6675665</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/the-hartford-appoints-priscilla-almodovar-to-its-board-of-directors-6675665</guid>
      <pubDate>Tue, 11 Aug 2026 20:05:00 GMT</pubDate>
    </item>
    <item>
      <title>Globally Ranked Flexible Legal Talent Company Latitude Opens Denver Office Led by Former Public Company General Counsel</title>
      <description>David Hamm Joins as Founding Partner as Growing Demand for Flexible Legal Talent Drives Continued ExpansionNASHVILLE, Tenn., Aug. 11, 2026 /PRNewswire/ -- Latitude, a Chambers and Partners globally ranked flexible legal talent company serving legal departments and law firms throughout the U.S. and internationally, today announced the opening of its newest regional office in Denver, to be led by David Hamm.
    
                
                    
                
    
A former public company general counsel and Big Law alum with nearly two decades of legal experience, Hamm will support corporate legal departments and law firms, providing former in-house and Big Law attorneys for contract e</description>
      <link>https://www.quantisnow.com/insight/globally-ranked-flexible-legal-talent-company-latitude-opens-denver-office-6675402</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/globally-ranked-flexible-legal-talent-company-latitude-opens-denver-office-6675402</guid>
      <pubDate>Tue, 11 Aug 2026 16:09:00 GMT</pubDate>
    </item>
    <item>
      <title>31-Year Industry Veteran with $145 Million in Assets Joins Ameriprise Financial for Innovative Technology and Supportive Culture</title>
      <description>
Mitchell Edenbaum joins the branch channel of Ameriprise from Oppenheimer &amp; Co. Inc.


Financial advisor Mitchell Edenbaum recently joined the branch channel of Ameriprise Financial, Inc. (NYSE:AMP) in Boca Raton, Fla. from Oppenheimer &amp; Co. Inc. with more than $145 million in client assets.


&quot;I was looking for a firm that is making meaningful investments in innovation, and I immediately saw the positive impact Ameriprise’s technology platform could have on my practice,&quot; said Edenbaum. &quot;What also stood out was the firm&apos;s clear commitment to helping advisors grow and deliver outstanding client service. From my first conversations with senior leadership, it was evident that Ameriprise is foc</description>
      <link>https://www.quantisnow.com/insight/31-year-industry-veteran-with-145-million-in-assets-joins-ameriprise-6675371</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/31-year-industry-veteran-with-145-million-in-assets-joins-ameriprise-6675371</guid>
      <pubDate>Tue, 11 Aug 2026 15:23:00 GMT</pubDate>
    </item>
    <item>
      <title>YY Group Holding Launches YY Logitech Pte. Ltd. to Accelerate Next-Generation Supply Chain Solutions</title>
      <description>Appoints Industry Veteran Sunther Manoher as Managing Director of YY LogitechSINGAPORE, Aug. 11, 2026 /PRNewswire/ -- YY Group Holding Limited (NASDAQ:YYGH) (&quot;YY Group&quot; or the &quot;Company&quot;), an AI-enabled workforce management platform and integrated facility management (IFM) provider operating across Asia and beyond, today announced the official incorporation of YY Logitech Pte. Ltd. (&quot;YY Logitech&quot;), a company expected to focus on logistics, relocation, workforce solutions, and technology-enabled supply chain services. Concurrently, YY Logitech appointed Sunther Manoher as its Managing Director to lead this new subsidiary.
    
                
                    
                
    
Leverag</description>
      <link>https://www.quantisnow.com/insight/yy-group-holding-launches-yy-logitech-pte-ltd-to-accelerate-6675290</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/yy-group-holding-launches-yy-logitech-pte-ltd-to-accelerate-6675290</guid>
      <pubDate>Tue, 11 Aug 2026 13:26:00 GMT</pubDate>
    </item>
    <item>
      <title>New Zealand Just Fast-Tracked a Gold-Antimony Mine and Cleared the Way for a First-Ever Drill Program</title>
      <description>News Provided by USA News Group on behalf of RUA Gold Inc.  In the span of six days, RUA GOLD received Fast-Track designation for Auld Creek and drill approval for Glamorgan. Two assets. Two milestones. Two distinct pathways toward value creation. One company.  VANCOUVER, British Columbia, Aug.  11, 2026  (GLOBE NEWSWIRE) -- USA News Group News Commentary - There is a version of the junior gold exploration story that runs on patience: drill, wait for results, drill again, wait longer. And then there is the version that runs on momentum -- where multiple catalysts are converging simultaneously, where the regulatory environment is actively accelerating rather than impeding development, and whe</description>
      <link>https://www.quantisnow.com/insight/new-zealand-just-fast-tracked-a-gold-antimony-mine-and-cleared-the-6675276</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/new-zealand-just-fast-tracked-a-gold-antimony-mine-and-cleared-the-6675276</guid>
      <pubDate>Tue, 11 Aug 2026 13:20:00 GMT</pubDate>
    </item>
    <item>
      <title>Universal Technical Institute, Inc. Celebrates Dallas Expansion</title>
      <description>UTI-Dallas offers additional training programs for up to 1,000 more studentsDALLAS and PHOENIX, Aug. 11, 2026 /PRNewswire/ -- Universal Technical Institute, Inc. (NYSE:UTI), a national leader in workforce solutions for transportation, skilled trades, healthcare and dental care programs, recently celebrated the expansion of its UTI-Dallas campus with a ceremonial ribbon-cutting. The event included public officials, community leaders and employer partners who honored the campus&apos; continued impact on workforce development in North Texas.
    
                
                    
                
    
&quot;This new facility underscores our ongoing commitment to offering industry-aligned training in </description>
      <link>https://www.quantisnow.com/insight/universal-technical-institute-inc-celebrates-dallas-expansion-6675262</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/universal-technical-institute-inc-celebrates-dallas-expansion-6675262</guid>
      <pubDate>Tue, 11 Aug 2026 13:15:00 GMT</pubDate>
    </item>
    <item>
      <title>Cyabra Accelerates Public Sector Expansion Amid Surging Global Demand for Narrative Intelligence with VP of U.S. Government Sales Appointment</title>
      <description>Building on strong market momentum, strategic partnerships, and industry recognition, Cyabra appoints U.S. State Department Veteran Keith E. Noble, Ph.D. as Vice President of Government Sales  New York, NY, Aug.  11, 2026  (GLOBE NEWSWIRE) --  Cyabra, Inc. (NASDAQ:CYAB) (&quot;Cyabra&quot; or the &quot;Company&quot;), a company whose artificial intelligence (&quot;AI&quot;)-powered platform helps governments and enterprises detect coordinated manipulation and protect digital trust, today announced the appointment of Keith E. Noble, Ph.D. as Vice President of Government Sales to support the Company’s continued expansion in the public sector, driven by surging demand for narrative intelligence across federal, state, and lo</description>
      <link>https://www.quantisnow.com/insight/cyabra-accelerates-public-sector-expansion-amid-surging-global-demand-for-6675206</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/cyabra-accelerates-public-sector-expansion-amid-surging-global-demand-for-6675206</guid>
      <pubDate>Tue, 11 Aug 2026 13:00:00 GMT</pubDate>
    </item>
    <item>
      <title>UC Berkeley to Join Applied Materials’ EPIC Center to Speed Chip Innovation</title>
      <description>Collaboration pairs UC Berkeley’s semiconductor research strength with Applied’s state-of-the-art equipment and process integration expertiseLocated in Silicon Valley, Applied’s EPIC Center provides industry-scale R&amp;D environment with access to cutting-edge chipmaking equipment to enable rapid co-innovation and faster commercialization  SANTA CLARA, Calif., Aug.  11, 2026  (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that the University of California, Berkeley will join the company’s EPIC Center in Silicon Valley as a research collaborator. Working side by side with Applied’s scientists and engineers, UC Berkeley faculty and students will pursue high-impact research programs t</description>
      <link>https://www.quantisnow.com/insight/uc-berkeley-to-join-applied-materials-epic-center-to-speed-6675199</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/uc-berkeley-to-join-applied-materials-epic-center-to-speed-6675199</guid>
      <pubDate>Tue, 11 Aug 2026 13:00:00 GMT</pubDate>
    </item>
    <item>
      <title>ONE Nuclear Acquires Amino Sustainability Group and Appoints Industry Veteran Christopher Hansmeyer as Chief Development Officer</title>
      <description>
Acquisition adds proprietary development methodology and institutional playbooks to accelerate project execution for AI data centers and integrated industrial energy campuses ahead of ONE Nuclear’s planned NASDAQ listing


ONE Nuclear Energy LLC (&quot;ONE Nuclear&quot; or the &quot;Company&quot;), an independent developer of large-scale energy infrastructure, today announced the acquisition of Amino Sustainability Group (&quot;Amino&quot;), a specialized energy and digital infrastructure development advisory firm. Terms of the transaction were not disclosed.


In conjunction with the acquisition, Christopher Hansmeyer, Founder and Managing Partner of Amino, has been appointed Chief Development Officer of ONE Nuclear. I</description>
      <link>https://www.quantisnow.com/insight/one-nuclear-acquires-amino-sustainability-group-and-appoints-industry-veteran-6675192</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/one-nuclear-acquires-amino-sustainability-group-and-appoints-industry-veteran-6675192</guid>
      <pubDate>Tue, 11 Aug 2026 12:59:00 GMT</pubDate>
    </item>
    <item>
      <title>American Ocean Minerals Appoints Paul Warmé as Chief Financial Officer</title>
      <description>
Seasoned mining and industrial executive brings more than 25 years of global finance, operations, and strategic leadership experience


American Ocean Minerals Corporation (&quot;AOMC&quot; or the &quot;Company&quot;) today announced that Paul Warmé has been appointed Chief Financial Officer. Through its previously announced merger with Odyssey Marine Exploration (NASDAQ:OMEX), AOMC is establishing a U.S.-based global supply chain for critical minerals and rare earth elements sourced from deep-sea polymetallic nodules, and Warmé’s appointment further strengthens the executive leadership team as the Company advances that mission.

This press release features multimedia. View the full release here: https://www.b</description>
      <link>https://www.quantisnow.com/insight/american-ocean-minerals-appoints-paul-warm-as-chief-financial-officer-6675096</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/american-ocean-minerals-appoints-paul-warm-as-chief-financial-officer-6675096</guid>
      <pubDate>Tue, 11 Aug 2026 12:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Locafy Appoints SaaS Growth Leader Liz Willits as Chief Marketing Officer to Accelerate Company-Wide Growth</title>
      <description>PERTH, Australia, Aug.  11, 2026  (GLOBE NEWSWIRE) -- Locafy Limited (NASDAQ:LCFY, LCFYW)) (&quot;Locafy&quot; or the &quot;Company&quot;), a globally recognized software-as-a-service (SaaS) technology company specializing in location-based Search Engine Optimization (SEO) and Answer Engine Optimization (AEO) solutions, today announced the appointment of experienced SaaS growth marketer Liz Willits as Chief Marketing Officer, serving on a fractional basis.  Willits will lead the Company’s global marketing strategy, brand positioning, customer acquisition, channel development, and recurring revenue growth. An immediate priority will be the go-to-market launch of Proteus™, Locafy’s new AI-powered website generati</description>
      <link>https://www.quantisnow.com/insight/locafy-appoints-saas-growth-leader-liz-willits-as-chief-marketing-6675077</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/locafy-appoints-saas-growth-leader-liz-willits-as-chief-marketing-6675077</guid>
      <pubDate>Tue, 11 Aug 2026 12:30:00 GMT</pubDate>
    </item>
    <item>
      <title>ManpowerGroup Elects John B. Gibson Jr. to Board of Directors</title>
      <description>MILWAUKEE, Wis., Aug. 11, 2026 /PRNewswire/ -- ManpowerGroup (NYSE:MAN) today announced the appointment of Paychex (NASDAQ:PAYX) President and Chief Executive Officer John B. Gibson, Jr. to its Board of Directors, effective September 1, 2026.
    
                
                    
                
    
&quot;John is an accomplished leader with deep experience across human capital management, technology-enabled services and business transformation,&quot; said Jonas Prising, ManpowerGroup Chair &amp; CEO. &quot;We are pleased to welcome him to our Board. His strategic perspective, operational expertise and track record of leading through change will strengthen our ability to evolve the business and advance o</description>
      <link>https://www.quantisnow.com/insight/manpowergroup-elects-john-b-gibson-jr-to-board-of-directors-6675024</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/manpowergroup-elects-john-b-gibson-jr-to-board-of-directors-6675024</guid>
      <pubDate>Tue, 11 Aug 2026 12:01:00 GMT</pubDate>
    </item>
    <item>
      <title>LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update</title>
      <description>Announced accelerated timing of topline data readout from the pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia in the first half of 2027  Announced plans for pipeline expansion of LB-102 into new neuropsychiatric indications with strong mechanistic rationale and validating clinical and real-world experience from amisulpride   Cash, cash equivalents, and marketable securities of $327.8 million as of June 30, 2026, and proceeds from recent $150.0 million private placement to fund pipeline expansion, expected to fund operations beyond Q2 2029, through multiple clinical milestones  NEW YORK, Aug.  11, 2026  (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (&quot;LB Pharmaceuticals&quot; or the &quot;Company&quot;)</description>
      <link>https://www.quantisnow.com/insight/lb-pharmaceuticals-reports-second-quarter-2026-financial-results-and-provides-6674990</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/lb-pharmaceuticals-reports-second-quarter-2026-financial-results-and-provides-6674990</guid>
      <pubDate>Tue, 11 Aug 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders</title>
      <description>Files Definitive Proxy Statement and Mails Letter to Stockholders  Urges Stockholders to Vote &quot;FOR&quot; All Six Anavex Director Nominees on the WHITE Proxy Card  Underscores PVG’s Lack of Clear Plan and Inexperienced Slate of Director Nominees   NEW YORK, Aug.  11, 2026  (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (&quot;Anavex&quot; or the &quot;Company&quot;) (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system (&quot;CNS&quot;) diseases with high unmet medical needs, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission (&quot;SEC&quot;) in connection with its upcoming 2026 Annual Meeting of Stockholders</description>
      <link>https://www.quantisnow.com/insight/anavex-life-sciences-highlights-highly-qualified-board-and-decisive-actions-6674986</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/anavex-life-sciences-highlights-highly-qualified-board-and-decisive-actions-6674986</guid>
      <pubDate>Tue, 11 Aug 2026 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Signet Jewelers Announces New Leadership for Zales, Banter and Blue Nile</title>
      <description>
Jamie Cygielman will lead Zales’ next phase of growth and innovation, while Pam Cloud will lead Blue Nile’s transformation as an elevated luxury brand, anchored in natural diamonds


Appointments advance Signet’s Grow Brand Love strategy to strengthen and differentiate its portfolio of brands


Signet Jewelers, whose portfolio includes, KAY Jewelers, Zales, Jared Jewelers, Blue Nile and Banter, today announced two significant brand leadership appointments that advance the company’s Grow Brand Love strategy.


Jamie Cygielman has been appointed President of Zales and Banter and Pam Cloud has joined Signet as President of Blue Nile.


&quot;Grow Brand Love is about creating distinctive brands with</description>
      <link>https://www.quantisnow.com/insight/signet-jewelers-announces-new-leadership-for-zales-banter-and-blue-6674957</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/signet-jewelers-announces-new-leadership-for-zales-banter-and-blue-6674957</guid>
      <pubDate>Tue, 11 Aug 2026 11:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Littelfuse Appoints Todd Kelsey to Board of Directors</title>
      <description>
Littelfuse, Inc. (NASDAQ:LFUS), a leader in developing smart solutions that enable safe and efficient electrical energy transfer, today announced the appointment of Todd Kelsey to the company’s board of directors. Kelsey was also appointed to the Compensation Committee.


&quot;We are pleased to welcome Todd to the Littelfuse Board of Directors,&quot; said Gordon Hunter, Littelfuse Chairman of the Board of Directors. &quot;Todd brings extensive global experience as well as technology, engineering, and manufacturing expertise across our end markets. His operational perspective, public company board experience, and track record of leading a multinational organization will be valuable as we continue to execu</description>
      <link>https://www.quantisnow.com/insight/littelfuse-appoints-todd-kelsey-to-board-of-directors-6674931</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/littelfuse-appoints-todd-kelsey-to-board-of-directors-6674931</guid>
      <pubDate>Tue, 11 Aug 2026 11:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Stardust Power Appoints Ray Rivers to Board of Directors</title>
      <description>GREENWICH, Conn., Aug.  11, 2026  (GLOBE NEWSWIRE) -- Stardust Power Inc. (NASDAQ:SDST) (&quot;Stardust Power&quot; or the &quot;Company&quot;), an American developer of battery-grade lithium carbonate, today announced the appointment of Mr. V. Ray Rivers to its Board of Directors (the &quot;Board&quot;), effective August 10, 2026. Mr. Rivers will also serve as a member of the Audit Committee and Compensation Committee of the Board.  Mr. Rivers brings more than three decades of experience in capital markets, institutional investments, and financial services. Throughout his career, he has held senior leadership positions with several leading Wall Street firms, including Bear Stearns, CRT Capital Group, Cantor Fitzgerald, </description>
      <link>https://www.quantisnow.com/insight/stardust-power-appoints-ray-rivers-to-board-of-directors-6674924</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/stardust-power-appoints-ray-rivers-to-board-of-directors-6674924</guid>
      <pubDate>Tue, 11 Aug 2026 11:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Ceragon Reports 2026 Second Quarter Financial Results</title>
      <description>Strong demand in India drives 14% year-over-year revenue growthROSH HA&apos;AIN, Israel, Aug. 11, 2026 /PRNewswire/ -- Ceragon (NASDAQ:CRNT), a leading solutions provider of end-to-end wireless connectivity, today reported its financial results for the second quarter period ended June 30, 2026.
    
                
                    
                
    
Q2 2026 Financial Highlights:Revenues of $93.9 millionGAAP Operating income of $0.2 million, non-GAAP operating income of $4.0 millionGAAP Net loss of $2.1 million, non-GAAP net income of $1.7 millionGAAP EPS of ($0.02) per diluted share, non-GAAP EPS of $0.02 per diluted shareQ2 2026 Business Highlights:India – Sequentially higher revenue an</description>
      <link>https://www.quantisnow.com/insight/ceragon-reports-2026-second-quarter-financial-results-6674856</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/ceragon-reports-2026-second-quarter-financial-results-6674856</guid>
      <pubDate>Tue, 11 Aug 2026 11:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights</title>
      <description>Company continues to prepare for late-stage clinical advancement of vopimetostat in combination with daraxonrasib for pancreatic cancer following positive Phase 1/2 data  Phase 1/2 data from combination study of vopimetostat + RAS(ON) inhibitors in pancreatic cancer to be presented at 2026 ESMO Congress  Key appointments further position Company for late-stage development and commercialization: Robert Azelby, Chairman of the Board of Directors and Fatma Ocak, Chief Commercialization Officer  Cash position of $1.0 billion as of June 30, 2026  BOSTON, Aug.  11, 2026  (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ:TNGX) (Tango or the Company), a clinical-stage biotechnology company commit</description>
      <link>https://www.quantisnow.com/insight/tango-therapeutics-reports-second-quarter-2026-financial-results-and-provides-6674843</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/tango-therapeutics-reports-second-quarter-2026-financial-results-and-provides-6674843</guid>
      <pubDate>Tue, 11 Aug 2026 11:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer</title>
      <description>WALTHAM, Mass., Aug.  11, 2026  (GLOBE NEWSWIRE) -- Kailera Therapeutics, Inc. (NASDAQ:KLRA) (Kailera), a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced the appointment of Nur Nicholson as Chief Technology Officer, effective August 31, 2026.  &quot;We are excited to welcome Nur as an executive at such a pivotal moment for Kailera,&quot; said Ron Renaud, President and Chief Executive Officer of Kailera. &quot;As we advance ribupatide injection through global Phase 3 trials, look to begin our Phase 3 program for ribupatide oral in the first half of next year, and continue the development of our broader pipeline, Nur’s track record of building resilient</description>
      <link>https://www.quantisnow.com/insight/kailera-therapeutics-appoints-nur-nicholson-as-chief-technology-officer-6674833</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/kailera-therapeutics-appoints-nur-nicholson-as-chief-technology-officer-6674833</guid>
      <pubDate>Tue, 11 Aug 2026 11:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Prelude Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update</title>
      <description>The Company expects to initiate its Phase 1 study of PRT13722, a first-in-class highly-selective oral KAT6A degrader in HR+ breast cancer in the fourth quarter  Presented preclinical data demonstrating differentiated profile of PRT13722, at the American Association for Cancer Research (AACR) Annual Meeting 2026  Enrollment continues in Phase 1 Study of PRT12396, mutant-selective JAK2V617F inhibitor in patients with polycythemia vera (PV) and myelofibrosis (MF)   Current cash runway expected into the second quarter of 2028 with $155 million in cash, cash equivalents, restricted cash and marketable securities as of June 30, 2026   WILMINGTON, Del., Aug.  11, 2026  (GLOBE NEWSWIRE) -- Prelude T</description>
      <link>https://www.quantisnow.com/insight/prelude-therapeutics-reports-second-quarter-2026-financial-results-and-provides-6674829</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/prelude-therapeutics-reports-second-quarter-2026-financial-results-and-provides-6674829</guid>
      <pubDate>Tue, 11 Aug 2026 11:00:00 GMT</pubDate>
    </item>
    <item>
      <title>CVRx Announces Sales Leadership Transition</title>
      <description>MINNEAPOLIS, Aug.  11, 2026  (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ:CVRX) (&quot;CVRx&quot;), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that Robert John, Chief Revenue Officer, will depart the company, and that Paul Verrastro will assume the role of Interim Head of Sales, effective immediately.  In his new role, Mr. Verrastro will lead CVRx&apos;s sales organization while the company conducts a search for a permanent successor.  Mr. Verrastro brings more than 30 years of medical device sales and marketing experience to the role. He has been with CVRx for o</description>
      <link>https://www.quantisnow.com/insight/cvrx-announces-sales-leadership-transition-6674824</link>
      <guid isPermaLink="true">https://www.quantisnow.com/insight/cvrx-announces-sales-leadership-transition-6674824</guid>
      <pubDate>Tue, 11 Aug 2026 11:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>